Screening for portopulmonary hypertension with transthoracic echocardiography: Implications for early mortality associated with liver transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 4, 2009, Pages 378-

  Ford, H James ^a   Aris, Robert M ^a   Andreoni, Kenneth ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD STANDARD; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HUMAN; LETTER; LIVER CONGESTION; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

EID: 68849090773     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.180.4.378     Document Type: Letter

References (4)

1. Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jaïs X, Yaïci A, Humbert M, Simmoneau G, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 2008;178:637-643.
2. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 2008;8:2445-2453.
3. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182.
4. Ramsay MA. Perioperative mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:451-452.